Journal article

Clozapine users in Australia: their characteristics and experiences of care based on data from the 2010 National Survey of High Impact Psychosis

DJ Siskind, M Harris, A Phillipou, VA Morgan, A Waterreus, C Galletly, VJ Carr, C Harvey, D Castle

Epidemiology and Psychiatric Sciences | Cambridge University | Published : 2017


Copyright © Cambridge University Press 2016Aims.: Clozapine is the most effective medication for treatment refractory schizophrenia. However, descriptions of the mental health and comorbidity profile and care experiences of people on clozapine in routine clinical settings are scarce. Using data from the 2010 Australian Survey of High Impact Psychosis, we aimed to examine the proportion of people using clozapine, and to compare clozapine users with other antipsychotic users on demographic, mental health, adverse drug reaction, polypharmacy and treatment satisfaction variables. Methods.: Data describing 1049 people with a diagnosis of schizophrenia or schizoaffective disorder, who reported tak..

View full abstract